15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The stability of egg phosphatidylcholine (EPC) and cholesterol (Chol) based liposomes and liposomes with the addition of the tetraether lipid glycerylcaldityl tetraether (GCTE) and the bio-enhancers cholylsarcosine, octadecanethiol and TPGS 1000 in Tris buffer pH 2, sodium taurocholate 10mM and pancreatin was compared. At pH 2 all formulations released nearly 100% of the small hydrophilic fluorescent marker carboxyfluorescein (CF) within the first 10min, whereas they were mostly stable in size as confirmed by dynamic light scattering (DLS) measurements. Also leakage of the macromolecule FITC-dextran 70kDa over 60min at pH 2 was at most 23.9%. After 20min in 10mM sodium taurocholate vesicles without GCTE showed a release of CF between 84.0% and 89.5%. In contrast, GCTE-stabilised formulations after 90min in sodium taurocholate exhibited a CF release between 36.6% and 69.0% depending on the addition of bio-enhancers. Pancreatin had a minor influence on liposome stability in all assays. It is possible to form EPC/Chol vesicles containing different types of bio-enhancers and to stabilise them with GCTE against bile salts. This type of liposomes could be a versatile tool for the oral delivery of drug substances with poor stability in the GI tract and low permeability.

          Related collections

          Author and article information

          Journal
          Int J Pharm
          International journal of pharmaceutics
          Elsevier BV
          1873-3476
          0378-5173
          Feb 28 2011
          : 405
          : 1-2
          Affiliations
          [1 ] Institute of Pharmacy and Molecular Biotechnology, Department of Pharmaceutical Technology and Biopharmacy, University of Heidelberg, Im Neuenheimer Feld 366, D-69120 Heidelberg, Germany.
          Article
          S0378-5173(10)00925-7
          10.1016/j.ijpharm.2010.12.005
          21145956
          18ca53f7-dddb-4bb7-9179-1108a947992a
          History

          Comments

          Comment on this article